Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-151282
Filing Date
2016-11-18
Accepted
2016-11-18 17:14:43
Documents
1
Period of Report
2016-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3238
  Complete submission text file 0001209191-16-151282.txt   4539
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1880 ELLINGTON WAY AUBURN AL 36830
Business Address
Lawrence Thomas R (Reporting) CIK: 0001408568 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 162008558